ADVFN - Advanced Financial Network.
HOME» NYSE » R » RMD Stock Price » RMD Stock News

Resmed Share News

 Resmed Inc. Stock Price
RMD Stock Price
 Resmed Inc. Stock Chart
RMD Stock Chart
 Resmed Inc. Stock News
RMD Stock News
 Resmed Inc. Company Information
RMD Company Information
 Resmed Inc. Stock Trades
RMD Stock Trades

Australia ACCC: ResMed Accepts Undertaking On Retail Price Maintenance

SYDNEY -(Dow Jones)- Sleep disorder device company ResMed Inc. (RMD.AU) has agreed to revise its internal fair-trading checks following an investigation of price-fixing by Australia's competition regulator. The Australian Competition and Consumer Commission said Tuesday it had investigated the company over whether it was telling accredited retailers that it would stop supplying its products if they sold them at less than a price specified by ResMed, a practice known as retail price maintenance. "The ACCC is concerned that between March and June 2009 ResMed is likely to have engaged in retail price maintenance," the ACCC said in a statement. ResMed has accepted a court-enforceable undertaking to write to its accredited retailers telling them they are free to set their own prices, and to amend its compliance program for Australian trade practices law, the ACCC said. ResMed did not immediately respond to a call for comment. -By David Fickling, Dow Jones Newswires; +61 2 8272 4689;

Stock News for Resmed (RMD)
10/18/201609:00:00National Sleep Survey Launch on "The Dr. Oz Show" to Determine...
10/14/201609:00:00Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep...
10/14/201609:00:00Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep...
09/27/201616:05:00ResMed to Announce First Quarter Fiscal Year 2017 Results
09/06/201608:51:00New Study Shows Using Non-Invasive Ventilation Therapy to Treat...
09/06/201601:00:00ResMed Expands COPD Offering as New Data Reveals Benefits of...
09/06/201601:00:00ResMed erweitert COPD-Angebot: Neue Daten zeigen Vorteile einer...
09/06/201601:00:00ResMed élargit son offre de traitement de la BPCO, alors que...
08/17/201617:17:00ResMed Takes Fisher & Paykel to Court over Patents
08/17/201617:10:00ResMed Takes Fisher & Paykel to Court over Patents
08/17/201617:10:00ResMed Takes Fisher & Paykel to Court over Patents
08/15/201619:03:00Fisher & Paykel Files Patent Infringement Claim Against ResMed
07/28/201616:05:00ResMed Inc. Announces Results for the Fourth Quarter of Fiscal...
07/26/201603:14:00Australia Stocks End up Slightly as Key Inflation Data Looms
07/07/201616:05:00ResMed to Announce Fourth Quarter Fiscal Year 2016 Results
07/07/201607:40:00What Investors are Making of These Medical Appliances and Equipment...
06/28/201609:00:00ResMed Awarded Group Purchasing Contract with Premier
06/20/201609:00:00ResMed Statement on Brightree Executive Appointments
06/13/201609:00:00Kaiser Permanente Study: ResMed Digital Platform Drives CPAP...
05/22/201602:40:00Adaptive Servo-ventilation (ASV) Therapy Suggests Positive Cardiovascular...

Resmed and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations